European Neuropsychopharmacology
Impact Factor Trend (2018–2026)
Clarivate IF trend for European Neuropsychopharmacology
SCImago Journal Rank citation prestige weighting
139 papers with at least that number of citations each
Aims & Scope
European Neuropsychopharmacology is the official publication of the European College of Neuropsychopharmacology (ECNP). In accordance with the mission of the College, the journal focuses on clinical and basic science contributions that advance our understanding of brain function and human behaviour and enable translation into improved treatments and enhanced public health impact in psychiatry. Recent years have been characterized by exciting advances in basic knowledge and available experimental techniques in neuroscience and genomics. However, clinical translation of these findings has not been as rapid. The journal aims to narrow this gap by promoting findings that are expected to have a major impact on both our understanding of the biological bases of mental disorders and the development and improvement of treatments, ideally paving the way for prevention and recovery.
Special Issues
Calls for PapersNo active Calls for Papers found for this journal.
WoS Categories & Quartiles
Detailed JCR / JCI category rankings and quartile breakdown from Clarivate
CLINICAL NEUROLOGY
NEUROSCIENCES
PHARMACOLOGY & PHARMACY
PSYCHIATRY
CLINICAL NEUROLOGY
NEUROSCIENCES
PHARMACOLOGY & PHARMACY
PSYCHIATRY
Annual Historical Statistics & Publications
Track annual publication volume, total citations, and Impact Factor evolution
SCImago & Scopus Journal Intelligence
Global SCImago ranking, SJR prestige index, Scopus coverage, and societal policy impact
Weighted prestige citation metric per document indexed in the Scopus database.
Average citations received per document published in the 2-year window.
Estimated Article Processing Charge for Open Access publication.
Scopus 3-Year Publication & Citation Window
Aggregated from Scopus database across the 3-year SJR evaluation window.
Societal Impact & Inclusivity (SCImago)
Citations in government and international policy documents
Percentage of female authors published in the journal
Real-world societal policy reach and author gender diversity tracked by SCImago.
Scopus Subject Categories
Journal Metrics & Citation Visualizations
Total Cites vs Self-Cites
Evaluation of scholarly independence and citation reach
Citations per Document
Citation metric windows across 2, 3, and 4 years
Chinese Academy of Sciences (CAS) Classification
Major / minor zone classification and CAS Early Warning List history
Academic Intelligence Overview & Context
ImpaQ AnalysisEuropean Neuropsychopharmacology (acronym: neupsy, abbr: EUR. NEUROPSYCHOPHARMACOL, ISSN: 0924-977X) is a peer-reviewed international scholarly journal in the field of Medicine, published by Elsevier in Netherlands since 1990. The periodical holds a Journal Impact Factor (JIF) of 8.10, ranking in quartile Q1 of Web of Science (SCIE), a Scopus SJR indicator of 2.334 (Q1), an H-index of 139.
The journal enforces rigorous peer evaluation with a publication frequency of Monthly, an annual output of approximately 136 scientific articles. In terms of accessibility and author fees, it operates under the Hybrid model with an estimated APC of $3,694 USD. It serves as a benchmark publication platform for academics, researchers, and doctoral candidates seeking global research visibility.
Publishing & Editorial Information
Detailed publisher, peer-review turnaround, and publication cycle specifications
Similar Journals in Discipline
Journals in the same research field with comparable impact metrics